Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival ...

Professor Oliver Bathe urges us to rethink papillary thyroid cancer, noting that “low risk” isn’t always synonymous with low ...

Thyroid cancer is one of the most treatable malignancies; papillary cases diagnosed early have a five‑year survival rate close to 100 percent, according to data summarised by oncology researchers.

The relative survival rate was higher or tended to be higher in most subgroups undergoing RAI therapy than in subgroups not undergoing RAI therapy. In high-risk differentiated thyroid cancer ...

Get Instant Summarized Text (Gist) Radioiodine therapy after surgery increases relative survival rates in differentiated thyroid cancer patients across all risk groups. The greatest benefit is ...